Calyxha
1 known investors
Find your way into Calyxha
Sign up to see every warm intro you have to Calyxha
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Calyxha team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Calyxha is a biotech company developing novel small molecule anti-inflammatory drugs for multiple inflammatory diseases. Its lead product, CAL-4, is in preclinical development as an alternative to corticosteroids for asthma.
Investors · 1
Frequently asked questions
- What does Calyxha do?
- Calyxha is a biotech company developing novel small molecule anti-inflammatory drugs for multiple inflammatory diseases. Its lead product, CAL-4, is in preclinical development as an alternative to corticosteroids for asthma.
- Who are Calyxha's investors?
- Calyxha's investors include Kinled Holding.